About this file

This document provides an award synopsis and related federal contract opportunity notice. The National Institute of Allergy and Infectious Diseases awarded Technical Resources International, Inc. an indefinite delivery/indefinite quantity contract with a maximum amount of $364,553,934 for preclinical and translational vaccine development for HIV and other candidate agents. The period of performance is from December 1, 2021 through November 30, 2028 under solicitation number 75N93019R00023. The place of performance and awardee is Technical Resources International, Inc. located in Bethesda, Maryland. The primary point of contact at the National Institute of Allergy and Infectious Diseases is the contracting officer, Kishan Patel.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

AWARD SYNOPSIS

Type: Award

Date of Award: December 1, 2021

Period of Performance (including all options): December 1, 2021 through November 30, 2028

Title: "PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR

HIV AND OTHER CANDIDATE AGENTS”

(RFP) No.: 75N93019R00023

NAICS: 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Contract Number: 75N93022D00008

Total Estimated Cost (Including all Options): $364,553,934 maximum amount (IDIQ)

Place of Performance/Awardee:

Technical Resources International, Inc. (TRI) 6500 Rock Spring Drive, Suite 650 Bethesda, MD 20817

DUNS: 057052391

Primary Point of Contact at NIAID: Kishan Patel Contracting Officer patelki@niaid.nih.gov mailto:patelki@niaid.nih.gov

File details come from the government source that posted it. Updated .